Woodline Partners’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-220,676
| Closed | -$16.6M | – | 957 |
|
|
2022
Q2 | $16.6M | Buy |
220,676
+137,820
| +166% | +$10.4M | 0.26% | 120 |
|
|
2022
Q1 | $2.23M | Sell |
82,856
-17,788
| -18% | -$478K | 0.04% | 367 |
|
|
2021
Q4 | $4.8M | Buy |
100,644
+50,416
| +100% | +$2.4M | 0.07% | 286 |
|
|
2021
Q3 | $3.34M | Buy |
50,228
+3,228
| +7% | +$214K | 0.05% | 319 |
|
|
2021
Q2 | $3.67M | Buy |
47,000
+800
| +2% | +$62.4K | 0.07% | 266 |
|
|
2021
Q1 | $4.37M | Buy |
+46,200
| New | +$4.37M | 0.1% | 207 |
|
|
2020
Q1 | – | Sell |
-199,378
| Closed | -$12.4M | – | 181 |
|
|
2019
Q4 | $12.4M | Buy |
+199,378
| New | +$12.4M | 0.51% | 61 |
|